Genetic testing for assessment of lynch syndrome in young patients with polyps.

Published on Jun 17, 2021in Digestive and Liver Disease3.57
· DOI :10.1016/J.DLD.2021.05.031
Ido Laish7
Estimated H-index: 7
(TAU: Tel Aviv University),
Yael Goldberg17
Estimated H-index: 17
(Rabin Medical Center)
+ 8 AuthorsGili Levi-Reznick (Rambam Health Care Campus)
Sources
Abstract
Abstract null null Background null Routine screening for establishing Lynch syndrome (LS) in young individuals diagnosed with adenomas is not recommended due to its low yield, and limited sensitivity of the employment of immunohistochemistry for DNA mismatch-repair proteins on polyps. Hence we aimed to evaluate the yield of germline mutational analysis in diagnosis of LS in a young Israeli cohort with colorectal adenomatous polyps. null null null Methods null Data were retrospectively collected on consecutive patients, age ≤ 45 years, who underwent colonoscopy with removal of at least one adenoma during 2015–2020, and subsequently genetic testing by multigene panel or LS-Jewish founder mutation panel. null null null Results null Overall, 92 patients were included (median age 35 years, range 23–45 years), of whom 79 (85.8%) underwent multigene panel genotyping, and 13 (14.2%) analysis for Jewish founder LS gene mutations. Altogether, 18 patients were identified with pathogenic mutations in actionable genes, including LS-associated genes in 6 (6.5%), BRCA2 in 2 (2.5%), GREM1 in 1(1.2%), and low-penetrance genes- APC I1307K and CHEK2- in 9 (11.4%) patients. Compared with non-LS patients, LS-carriers had a significantly higher median PREMM5 score (2.6 vs. 1.3; P = 0.04). null null null Conclusions null Young individuals diagnosed with adenomatous polyps should be offered genetic testing when fulfilling clinical guidelines for LS, but weight should also be given to adenoma characteristics in the PREMM5 score.
📖 Papers frequently viewed together
4 Citations
7 Authors (Yun Xu, ..., Fangqi Liu)
1 Citations
References36
Newest
#1Inbal Kedar (Rabin Medical Center)H-Index: 8
#2L Walsh (UW: University of Washington)
Last. Yael Goldberg (Rabin Medical Center)H-Index: 17
view all 23 authors...
Lynch syndrome is an inherited cancer predisposition syndrome caused by germline defects in any of the mismatch repair (MMR) genes. Diagnosis of carriers makes precision prevention, early detection, and tailored treatment possible. Herein we report a novel founder deletion of 18,758 bp, mediated by Alu repeats on both sides, detected in Ethiopian Jews. The deletion, which encompasses exon 9-10 of the MSH2 coding sequence, is associated mainly with early-onset MSH2/MSH6-deficient colorectal cance...
1 CitationsSource
#1Mary B. Daly (Fox Chase Cancer Center)H-Index: 88
#1Mary B. Daly (Fox Chase Cancer Center)H-Index: 46
Last. Susan Darlow (National Comprehensive Cancer Network)H-Index: 22
view all 33 authors...
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic provide recommendations for genetic testing and counseling for hereditary cancer syndromes, and risk management recommendations for patients who are diagnosed with syndromes associated with an increased risk of these cancers. The NCCN panel meets at least annually to review comments, examine relevant new data, and reevaluate and update recommendations. These NCCN Guidelines Insights summarize the panel...
139 CitationsSource
#1Parag D Dabir (Radboud University Nijmegen)H-Index: 2
#2Carlijn E Bruggeling (Radboud University Nijmegen)H-Index: 1
Last. Iris D. Nagtegaal (Radboud University Nijmegen)H-Index: 8
view all 8 authors...
The colorectal cancer spectrum has changed due to population screening programs, with a shift toward adenomas and early cancers. Whether it would be a feasible option to test these adenomas for detection of Lynch syndrome (LS) patients is unclear. Through meta-analysis and systematic review, risk factors for DNA mismatch repair deficiency (dMMR) and microsatellite instability (MSI) in adenomas were identified in LS and unselected patient cohorts. Data were extracted for patient age and MMR varia...
9 CitationsSource
#1Mev Dominguez-Valentin (Oslo University Hospital)H-Index: 14
#2Julian R. Sampson (Cardiff University)H-Index: 78
Last. Pål Møller (University of Oslo)H-Index: 55
view all 88 authors...
Pathogenic variants affecting MLH1, MSH2, MSH6, and PMS2 cause Lynch syndrome and result in different but imprecisely known cancer risks. This study aimed to provide age and organ-specific cancer risks according to gene and gender and to determine survival after cancer. We conducted an international, multicenter prospective observational study using independent test and validation cohorts of carriers of class 4 or class 5 variants. After validation the cohorts were merged providing 6350 particip...
117 CitationsSource
#1Robin B. Mendelsohn (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 13
#2Keri HerzogH-Index: 2
Last. Moshe Shike (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 62
view all 6 authors...
Abstract Background The frequency of mismatch repair (MMR) deficiency (dMMR) in patients Patients and Methods We identified all patients aged 18 to 49 years who had undergone colonoscopy at Memorial Sloan Kettering Cancer Center from 2008 to 2013 and were identified as having tubular, villous, or tubulovillous adenomas on pathology. Patients with a personal history of colorectal cancer, polyposis syndrome, or inflammatory bowel disease before colonoscopy were excluded. Age, demographic data, fam...
11 CitationsSource
#1Sari Lieberman (Shaare Zedek Medical Center)H-Index: 8
#2Tom Walsh (UW: University of Washington)H-Index: 78
Last. Yael Goldberg (Hadassah Medical Center)H-Index: 17
view all 18 authors...
Hereditary mixed polyposis syndrome is a rare colon cancer predisposition syndrome caused by a duplication of a noncoding sequence near the gremlin 1, DAN family BMP antagonist gene (GREM1) originally described in Ashkenazi Jews. Few families with GREM1 duplications have been described, so there are many questions about detection and management. We report 4 extended families with the duplication near GREM1 previously found in Ashkenazi Jews; 3 families were identified at cancer genetic clinics i...
16 CitationsSource
#1Fay KastrinosH-Index: 16
#2Hajime UnoH-Index: 49
Last. Sapna SyngalH-Index: 75
view all 14 authors...
PurposeCurrent Lynch syndrome (LS) prediction models quantify the risk to an individual of carrying a pathogenic germline mutation in three mismatch repair (MMR) genes: MLH1, MSH2, and MSH6. We developed a new prediction model, PREMM5, that incorporates the genes PMS2 and EPCAM to provide comprehensive LS risk assessment.Patients and MethodsPREMM5 was developed to predict the likelihood of a mutation in any of the LS genes by using polytomous logistic regression analysis of clinical and germline...
63 CitationsSource
#1Matthew B. Yurgelun (Harvard University)H-Index: 23
#2Brian A. AllenH-Index: 11
Last. Sapna SyngalH-Index: 75
view all 10 authors...
Background & Aims Multigene panels are commercially available tools for hereditary cancer risk assessment that allow for next-generation sequencing of numerous genes in parallel. However, it is not clear if these panels offer advantages over traditional genetic testing. We investigated the number of cancer predisposition gene mutations identified by parallel sequencing in individuals with suspected Lynch syndrome. Methods We performed germline analysis with a 25-gene, next-generation sequencing ...
165 CitationsSource
#1Matthew F. Kalady (Cleveland Clinic)H-Index: 49
#2Sara E. Kravochuck (Cleveland Clinic)H-Index: 4
Last. James M. Church (Cleveland Clinic)H-Index: 99
view all 5 authors...
BACKGROUND:Patients with 10 or more lifetime adenomas are candidates for genetic counseling and testing for polyposis syndromes. Lynch syndrome falls under the umbrella of hereditary nonpolyposis colorectal cancer, and it is assumed that patients with Lynch syndrome do not develop multiple adenomas.
22 CitationsSource
#1Sue Richards (OHSU: Oregon Health & Science University)H-Index: 6
#2Nazneen Aziz (Boston Children's Hospital)H-Index: 20
Last. Heidi L. Rehm (Harvard University)H-Index: 71
view all 12 authors...
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
9,921 CitationsSource
Cited By0
Newest